Superpower launches peptide library mapping 152 compounds to the body, reviewed by physicians

Superpower has released a Peptide Library covering 152 compounds, ranging from approved drugs to those still in trials, organized by where they act in the body. Each peptide has a dedicated page reviewed by a physician and fully cited, detailing evidence strength, FDA status, mechanism of action, and findings from human studies. The company contrasts FDA-approved semaglutide with BPC-157, noting that a 2025 review found 35 of 36 BPC-157 studies were conducted in animals or the lab. The announcement encourages readers to "know the science before you buy the hype."

✨ AI summary of the linked source — not editorial content.

Explore the topic

• Launch